Holding/activity history for  GSK plc (GSK)
Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
2024   Q3 | 50,047,977 | 1.82 | $40.88 | ||
2024   Q2 | 50,047,977 | 1.81 | $38.50 | ||
2024   Q1 | 50,047,977 | 1.98 | $42.87 | ||
2023   Q4 | 50,047,977 | 1.91 | $37.06 | ||
2023   Q3 | 50,047,977 | 1.99 | Add 0.54% | 0.01 | $36.25 |
2023   Q2 | 49,780,637 | 1.95 | Add 0.37% | 0.01 | $35.64 |
2023   Q1 | 49,599,557 | 2.01 | Add 9.10% | 0.17 | $35.58 |
2022   Q4 | 45,460,757 | 1.84 | Buy | 1.84 | $35.14 |
2022   Q3 | 0 | 0 | Sell 100.00% | 2.66 | |
2022   Q2 | 51,376,172 | 2.66 | Reduce 13.26% | 0.41 | $43.53 |
2022   Q1 | 59,228,772 | 2.68 | $43.56 | ||
2021   Q4 | 59,228,772 | 2.73 | Add 0.72% | 0.02 | $44.10 |
2021   Q3 | 58,806,872 | 2.49 | Add 0.11% | 0.00 | $38.21 |
2021   Q2 | 58,741,472 | 2.67 | Add 0.76% | 0.02 | $39.82 |
2021   Q1 | 58,296,600 | 2.65 | Add 40.38% | 0.76 | $35.69 |
2020   Q4 | 41,528,300 | 2.18 | Add 42.80% | 0.65 | $36.80 |
2020   Q3 | 29,082,200 | 1.82 | Add 11.49% | 0.19 | $37.64 |
2020   Q2 | 26,084,900 | 1.79 | Reduce 6.79% | 0.13 | $40.79 |
2020   Q1 | 27,984,900 | 2.08 | Reduce 9.45% | 0.22 | $37.89 |
2019   Q4 | 30,905,200 | 1.97 | Reduce 3.22% | 0.07 | $46.99 |
2019   Q3 | 31,935,000 | 2.01 | $42.68 | ||
2019   Q2 | 31,935,000 | 1.85 | $40.02 | ||
2019   Q1 | 31,935,000 | 1.98 | Reduce 0.20% | 0.00 | $41.79 |
2018   Q4 | 32,000,000 | 2.02 | $38.21 | ||
2018   Q3 | 32,000,000 | 1.76 | $40.17 | ||
2018   Q2 | 32,000,000 | 1.87 | $40.31 | ||
2018   Q1 | 32,000,000 | 1.83 | Add 10.59% | 0.18 | $39.07 |
2017   Q4 | 28,936,700 | 1.47 | Add 163.30% | 0.91 | $35.47 |
2017   Q3 | 10,990,050 | 0.66 | Buy | 0.66 | $40.60 |
2015   Q3 | 0 | 0 | Sell 100.00% | 0.40 | |
2015   Q2 | 5,717,547 | 0.40 | Reduce 48.40% | 0.38 | $41.65 |
2015   Q1 | 11,081,400 | 0.86 | Reduce 2.64% | 0.02 | $46.15 |
2014   Q4 | 11,381,400 | 0.82 | Reduce 30.30% | 0.36 | $42.74 |
2014   Q3 | 16,329,300 | 1.30 | Reduce 33.17% | 0.65 | $45.97 |
2014   Q2 | 24,435,300 | 2.25 | $53.48 | ||
2014   Q1 | 24,435,300 | 2.40 | Reduce 1.09% | 0.03 | $53.43 |
2013   Q4 | 24,703,400 | 2.44 | Reduce 1.98% | 0.05 | $53.39 |
2013   Q3 | 25,203,400 | 2.59 | $50.17 | ||
2013   Q2 | 25,203,400 | 2.75 | Reduce 1.63% | 0.05 | $49.97 |
2013   Q1 | 25,621,200 | 2.72 | Reduce 0.19% | 0.01 | $46.91 |
2012   Q4 | 25,671,200 | 2.83 | Add 9.74% | 0.25 | $43.47 |
2012   Q3 | 23,392,100 | 2.71 | Add 4.70% | 0.12 | $46.24 |
2012   Q2 | 22,342,100 | 2.70 | Reduce 2.40% | 0.07 | $45.57 |
2012   Q1 | 22,892,100 | 2.55 | Reduce 1.71% | 0.04 | $44.91 |
2011   Q4 | 23,290,800 | 2.92 | Reduce 4.12% | 0.13 | $45.63 |
2011   Q3 | 24,290,800 | 2.95 | Reduce 13.01% | 0.44 | $41.29 |
2011   Q2 | 27,925,000 | 2.76 | $42.90 | ||
2011   Q1 | 27,925,000 | 2.41 | Add 1.29% | 0.03 | $38.41 |
2010   Q4 | 27,569,000 | 2.54 | Reduce 0.92% | 0.02 | $39.22 |
2010   Q3 | 27,824,300 | 2.79 | Reduce 0.71% | 0.02 | $39.52 |
2010   Q2 | 28,024,300 | 2.62 | Add 0.72% | 0.02 | $34.01 |
2010   Q1 | 27,824,300 | 2.55 | $38.52 | ||
2009   Q4 | 27,824,300 | 2.99 | $42.25 | ||
2009   Q3 | 27,824,300 | 2.83 | $39.51 | ||
2009   Q2 | 27,824,300 | 2.98 | Reduce 0.05% | 0.00 | $35.34 |
2009   Q1 | 27,838,300 | 3.28 | Reduce 3.80% | 0.13 | $31.07 |
2008   Q4 | 28,938,300 | 3.37 | Reduce 5.86% | 0.21 | $37.27 |
2008   Q3 | 30,738,300 | 3.03 | Reduce 4.06% | 0.13 | $43.46 |
2008   Q2 | 32,038,300 | 2.74 | Add 0.04% | 0.00 | $44.22 |
2008   Q1 | 32,025,900 | 2.54 | Add 1.93% | 0.05 | $42.43 |
2007   Q4 | 31,420,700 | 2.54 | Add 0.01% | 0.00 | $50.39 |
2007   Q3 | 31,418,900 | 2.46 | Add 3.97% | 0.09 | $53.20 |
2007   Q2 | 30,218,900 | 2.25 | Add 22.51% | 0.41 | $52.37 |
2007   Q1 | 24,666,900 | 2.08 | Add 68.22% | 0.84 | $55.26 |
2006   Q4 | 14,663,800 | 1.22 | $52.76 |